Directory
>
Andy Murphy
Andy Murphy
VP, Early Research | Kriya Therapeutics, Inc.
Cary, North Carolina, United States
Andy Murphy
Summary
Andy Murphy is a seasoned professional in bioconjugate chemistry and biotechnology, currently serving as the Vice President of Early Research at Kriya Therapeutics. With a strong academic background, including a Ph.D. from Stanford University, Andy has a rich history of leadership in drug delivery technologies and particle fabrication. His experience spans multiple organizations, including founding his own consulting firm, Kitty Hawk Biosciences, where he focused on gene therapies. Andy is recognized for his contributions to the development of novel therapeutic delivery systems, particularly in vaccines and nucleotides. He has authored several publications in prestigious journals, showcasing his expertise and innovative approaches in the field. His technical skills encompass a wide range of methodologies, including GMP processes and analytical techniques. Andy is passionate about advancing biotherapeutics and improving patient outcomes through innovative research.
Andy Murphy
Work Experience
VP, Early Research at
Kriya Therapeutics, Inc.
January 2023 - Present
Sr. Director, Early Research at
Kriya Therapeutics
August 2021 - March 2023
President/Founder at
Kitty Hawk Biosciences
June 2017 - August 2021
Group Leader / Sr. Scientist at
KBI Biopharma
August 2016 - June 2017
Sr. Research Scientist at
Duke University Health System
October 2015 - August 2016
Director of Bioseparations Technology at
Proteovec
March 2014 - September 2015
Principal Scientist at
Liquidia Corporation
June 2011 - March 2014
Senior Scientist at
Liquidia Corporation
December 2007 - June 2011
Scientist at
Liquidia Corporation
February 2007 - December 2007
Postdoctoral Associate at
University Of North Carolina At Chapel Hill
January 2006 - January 2007
Graduate Assistant at
Stanford University
September 2000 - December 2005
Research Technologist / Assistant Manager Keck Biophysics Facility at
Northwestern University
January 1998 - January 2000
Andy Murphy
Education
Stanford University, Ph.D
January 2000 - January 2005
Oberlin College, Ba
January 1994 - January 1998
Frequently Asked Questions about Andy Murphy
What is Andy Murphy email address?
Andy Murphy's primary email address is *******@kriyatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Andy Murphy work for?
Andy Murphy is a VP, Early Research at Kriya Therapeutics, Inc., a company specializing in Biological products, except diagnostic.
Where Andy Murphy graduated from?
Andy Murphy holds a degree in Chemistry from Stanford University.
How can I directly contact Andy Murphy?
To contact Andy Murphy directly, you can use the email address *******@kriyatx.com. Complete contact information is available upon registration with Muraena.
Who is Andy Murphy?
Andy Murphy is a seasoned professional in bioconjugate chemistry and biotechnology, currently serving as the Vice President of Early Research at Kriya Therapeutics. With a strong academic background, including a Ph.D. from Stanford University, Andy has a rich history of leadership in drug delivery technologies and particle fabrication. His experience spans multiple organizations, including founding his own consulting firm, Kitty Hawk Biosciences, where he focused on gene therapies. Andy is recognized for his contributions to the development of novel therapeutic delivery systems, particularly in vaccines and nucleotides. He has authored several publications in prestigious journals, showcasing his expertise and innovative approaches in the field. His technical skills encompass a wide range of methodologies, including GMP processes and analytical techniques. Andy is passionate about advancing biotherapeutics and improving patient outcomes through innovative research.
Andy`s contact details
*******@kriyatx.com
***********@dukemedicine.org
*******@kbibiopharma.com
Colleagues
SVP, Technical Operations
Vice President Supply Chain
Vice President, BioAnalytical & Immunology
Senior Vice President of Immunology and Bioanalysis
President & Chief Operating Officer
Vice President, Regulatory Affairs
Vice President, Program Management